What You Should Know:

你应该知道的：

–

–

Eli

埃利

, a health technology company, announced it has raised $12M in Series A funding to scale its vision for real-time hormone monitoring led by

，一家健康技术公司，宣布已完成1200万美元的A轮融资，以扩大其由实时激素监测引领的愿景。

BDC Capital’s

BDC资本的

Thrive Venture Fund

兴旺风险基金

, with participation from

，参与方包括

Muse Capital

缪斯资本

,

，

TELUS Global Ventures

TELUS环球风险投资

, and other key investors. This brings the company’s total funding to $20M.

，以及其他主要投资者。这使得该公司的总融资达到 2000 万美元。

– The new capital will be used to bring the Hormometer™—the world’s first instant hormone monitoring system—to millions of people, addressing a significant gap in personalized health.

新资金将用于将Hormometer™——全球首款即时激素监测系统——带给数百万人，填补个性化健康领域的重大空白。

The Problem: Challenges with Hormone Health

问题：激素健康面临的挑战

Hormones are fundamental to nearly every aspect of health, from stress, energy, and sleep to fertility and longevity. Yet, traditional testing methods provide only a single snapshot in time, often days or weeks after symptoms appear. This is a critical limitation, as hormones like cortisol can fluctuate by as much as 100% in a single hour..

激素对健康的几乎所有方面都至关重要，从压力、能量、睡眠到生育能力和寿命。然而，传统的检测方法只能提供某个时间点的单一快照，常常在症状出现数天或数周后才进行检测。这是一个关键的局限性，因为像皮质醇这样的激素在一小时内可能会波动多达100%。

This “snapshot” approach has led to a widespread and underdiagnosed health crisis:

这种“快照”式的方法导致了一场广泛且未被充分诊断的健康危机：

1 in 3 adults show signs of cortisol dysregulation.

三分之一的成年人显示出皮质醇失调的迹象。

60% of adults will experience symptoms related to hormone imbalances.

60% 的成年人将经历与荷尔蒙失调相关的症状。

Despite how common these issues are, the tools to understand our hormones in real time have not existed—until now.

尽管这些问题很常见，但直到现在，我们还没有工具可以实时了解我们的荷尔蒙。

The Solution: The Hormometer™

解决方案：荷尔蒙测量仪™

Eli has built what was missing: a way to track hormones instantly using just saliva and a smartphone. The Hormometer™ is the first real-time hormone monitor, providing results in minutes without labs, sample shipments, or waiting. The new layer of digital health intelligence gives users a live view of their biology, providing not just a number, but context.

Eli 创造了此前缺失的东西：一种仅用唾液和智能手机即可即时追踪激素的方法。Hormometer™ 是首个实时激素监测仪，无需实验室、样本运输或等待，几分钟内即可提供结果。这一全新的数字健康智能层面让用户能够实时查看自己的生理状况，不仅提供数据，还赋予其背景意义。

This allows individuals to understand what’s happening in their bodies now and take immediate, informed action..

这使得个人能够了解他们身体当前的状况，并立即采取明智的行动。

The Hormometer™ is the result of years of R&D and deep technology development. Eli has built an end-to-end system that includes:

Hormometer™ 是多年研发和深度技术开发的成果。Eli 构建了一个端到端的系统，包括：

Biochemistry

生物化学

designed specifically for microfluidics.

专为微流体设计。

AI and machine learning

人工智能与机器学习

to interpret dynamic hormone signals.

解读动态激素信号。

Custom hardware

自定义硬件

manufactured in-house.

内部制造。

12+ patent-pending innovations

12+ 项正在申请专利的创新

across science, engineering, and design.

横跨科学、工程和设计。

After years of development, Eli has reached commercial readiness, completed third-party validations, and is currently running a private beta with early adopters.

经过多年的发展，Eli已经达到了商业准备就绪的程度，完成了第三方验证，并且目前正在与早期采用者进行私人测试。

Expansion Plans

扩展计划

The new funding will enable Eli to accelerate its growth, with a focus on:

新资金将使Eli能够加速其增长，重点在于：

Scaling production

扩大规模生产

of the Hormometer™.

荷尔蒙计™。

Expanding access

扩大访问范围

to a wider audience.

面向更广泛的受众。

Unlocking more biomarkers

解锁更多生物标志物

, starting with cortisol and progesterone.

，首先从皮质醇和黄体酮开始。